The effects of switching antidepressants on endoxifen exposure.
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2011
At a glance
- Drugs Escitalopram (Primary) ; Paroxetine (Primary) ; Tamoxifen; Venlafaxine
- Indications Breast cancer
- Focus Adverse reactions; Pharmacogenomic; Pharmacokinetics
- Acronyms Switch
- 11 Nov 2011 New source identified and integrated (Netherlands Trial Register)
- 11 Nov 2011 Planned end date changed to 7 Nov 2014 as reported by Netherlands Trial Register.
- 09 Nov 2011 New trial record